Last updated: January 8, 2022
Sponsor: Health Education Research Foundation (HERF)
Overall Status: Active - Recruiting
Phase
N/A
Condition
Bursitis
Treatment
N/AClinical Study ID
NCT05189626
142/IREF/RMU/2021
Ages 20-60 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age between 20 and 60 years.
- Duration of complaint for more than 3 months.
- Gender: Both Male and Female.
- Patients with idiopathic frozen shoulder
- Patients having restriction in more than 2 ranges
- Patients with diabetes
Exclusion
Exclusion Criteria:
- Shoulder dislocation, fracture or labral tear.
- Shoulder girdle motor control deficit associated with neurological disorder.
- Any bony deformities acquired or congenital in glenohumeral joint.
- Patients with language barrier.
Study Design
Total Participants: 30
Study Start date:
December 06, 2021
Estimated Completion Date:
March 31, 2022
Study Description
Connect with a study center
Holy family hospital
Rawalpindi, Punjab 4400
PakistanActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.